Ontario Institute for Cancer Research
28
2
4
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
21.4%
6 terminated/withdrawn out of 28 trials
68.4%
-18.1% vs industry average
7%
2 trials in Phase 3/4
8%
1 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Role: collaborator
Pancreatic Adenocarcinoma Signature Stratification for Treatment
Role: collaborator
Province of Ontario Strategy for Personalized Management of Pancreatic Cancer Trial
Role: collaborator
Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy
Role: collaborator
Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
Role: collaborator
......SMARTEST Trial......
Role: collaborator
ARREST - A Phase I Study of SABR for Poly-metastatic Disease
Role: collaborator
--SuPERIOR Trial--
Role: collaborator
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Role: collaborator
Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection
Role: collaborator
Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI
Role: collaborator
Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer
Role: collaborator
Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer
Role: collaborator
PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer
Role: collaborator
Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC
Role: collaborator
A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer
Role: collaborator
Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer
Role: collaborator
Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy
Role: collaborator
INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer
Role: collaborator
Preventing Cardiac Sequelae in Pediatric Cancer Survivors
Role: collaborator